| 1 | serious | 12,810 |
| 2 | device-related | 151 |
| 3 | grave | 96 |
| 4 | non-serious | 94 |
| 5 | nonserious | 60 |
| 6 | transfusion-related | 51 |
| 7 | nonocular | 44 |
| 8 | sedation-related | 31 |
| 9 | steroid-related | 26 |
| 10 | lead-related | 18 |
| 11 | corticosteroid-related | 14 |
| 12 | prolactin-related | 14 |
| 13 | glaucoma-related | 13 |
| 14 | late-occurring | 13 |
| 15 | non-ocular | 10 |
| 16 | multiform | 8 |
| 17 | bleb-related | 7 |
| 18 | eps-related | 7 |
| 19 | warfarin-associated | 7 |
| 20 | antidepressant-associated | 6 |
| 21 | cdc-defined | 6 |
| 22 | hyperglycemia-related | 6 |
| 23 | steroid-associated | 6 |
| 24 | triptan-related | 6 |
| 25 | cast-related | 5 |
| 26 | cord-related | 5 |
| 27 | glucocorticoid-related | 5 |
| 28 | hypothermia-related | 5 |
| 29 | immobility-related | 5 |
| 30 | mechanism-related | 5 |
| 31 | supplement-related | 5 |
| 32 | ameliorable | 4 |
| 33 | cbt-related | 4 |
| 34 | incision-related | 4 |
| 35 | non-ms-related | 4 |
| 36 | nonthrombotic | 4 |
| 37 | owner-reported | 4 |
| 38 | vibration-related | 4 |
| 39 | adequate/three | 3 |
| 40 | anesthetic-related | 3 |
| 41 | corticosteroid-associated | 3 |
| 42 | cotc-related | 3 |
| 43 | death/severe | 3 |
| 44 | deployment-related | 3 |
| 45 | extra-gastrointestinal | 3 |
| 46 | fhab-associated | 3 |
| 47 | gc-related | 3 |
| 48 | lansoprazole-associated | 3 |
| 49 | menstrual-associated | 3 |
| 50 | notch-related | 3 |
| 51 | probiotic-related | 3 |
| 52 | severe/serious | 3 |
| 53 | adnexal/orbital | 2 |
| 54 | aed-related | 2 |
| 55 | aes/serious | 2 |
| 56 | antiadalimumab | 2 |
| 57 | bradykinetic | 2 |
| 58 | counter-balancing | 2 |
| 59 | debilitative | 2 |
| 60 | drink-related | 2 |
| 61 | en-related | 2 |
| 62 | erythropoietin-related | 2 |
| 63 | extradigestive | 2 |
| 64 | glucocorticosteroid-related | 2 |
| 65 | glutamine-related | 2 |
| 66 | high-causality | 2 |
| 67 | influenzal | 2 |
| 68 | ipilimumab-associated | 2 |
| 69 | ivb-related | 2 |
| 70 | life-threating | 2 |
| 71 | lifethreatening | 2 |
| 72 | lsa-related | 2 |
| 73 | mars-related | 2 |
| 74 | medically-confirmed | 2 |
| 75 | nonneurological | 2 |
| 76 | nsaid-type | 2 |
| 77 | platelet-related | 2 |
| 78 | postarthrodesis | 2 |
| 79 | radiotherapy-associated | 2 |
| 80 | regadenoson-related | 2 |
| 81 | secretion-related | 2 |
| 82 | serious/sentinel | 2 |
| 83 | sleeprelated | 2 |
| 84 | stepwise-heated | 2 |
| 85 | suicidality-related | 2 |
| 86 | tacrolimus-related | 2 |
| 87 | trichlorobenzenes | 2 |
| 88 | vestibulo-cerebellar | 2 |
| 89 | voriconazole-related | 2 |
| 90 | work-associated | 2 |
| 91 | worst-grade | 2 |
| 92 | 'darker | 1 |
| 93 | 1,404,470 | 1 |
| 94 | 11,220 | 1 |
| 95 | 11.local | 1 |
| 96 | 12,907 | 1 |
| 97 | 190-surface | 1 |
| 98 | 2p=0.04 | 1 |
| 99 | 6.06.no | 1 |
| 100 | 9029 | 1 |
| 101 | aas-related | 1 |
| 102 | abcd-related | 1 |
| 103 | acei-related | 1 |
| 104 | acute/long-term | 1 |
| 105 | adhesive-related | 1 |
| 106 | advanced-adiabatic | 1 |
| 107 | agomelatine-related | 1 |
| 108 | alkyldiamine | 1 |
| 109 | altered-chemistry | 1 |
| 110 | analysis.more | 1 |
| 111 | antibacterial-related | 1 |
| 112 | anticholinergic-emergent | 1 |
| 113 | anticholinergic-related | 1 |
| 114 | antifungal-related | 1 |
| 115 | atenolol-associated | 1 |
| 116 | atg-related | 1 |
| 117 | atorvastatin-related | 1 |
| 118 | aucbt-related | 1 |
| 119 | benznidazole-related | 1 |
| 120 | best-possible-self | 1 |
| 121 | bgt226-related | 1 |
| 122 | biapenem-related | 1 |
| 123 | biopsy/normal | 1 |
| 124 | bipack | 1 |
| 125 | bosentan-associated | 1 |
| 126 | brain/head | 1 |
| 127 | bupivacaine-related | 1 |
| 128 | cannabinoid-type | 1 |
| 129 | cannabis’s | 1 |
| 130 | cardiophobic | 1 |
| 131 | carlumab-related | 1 |
| 132 | catheterisation-related | 1 |
| 133 | ceramic-related | 1 |
| 134 | chemo-synthetic | 1 |
| 135 | cinitapride-related | 1 |
| 136 | classical-type | 1 |
| 137 | clomipramine-related | 1 |
| 138 | cms-defined | 1 |
| 139 | cmx001-related | 1 |
| 140 | cns-based | 1 |
| 141 | commonly-occurring | 1 |
| 142 | constellation-labeled | 1 |
| 143 | cr-related | 1 |
| 144 | csc-related | 1 |
| 145 | ctx-m-14/15 | 1 |
| 146 | cya-associated | 1 |
| 147 | cyclopropane-containing | 1 |
| 148 | dermacyn-related | 1 |
| 149 | device-correlated | 1 |
| 150 | ebola-specific | 1 |
| 151 | ecp-related | 1 |
| 152 | efficacy.minor | 1 |
| 153 | embolization-related | 1 |
| 154 | emollient-related | 1 |
| 155 | endocuff-associated | 1 |
| 156 | entry-related | 1 |
| 157 | environ- | 1 |
| 158 | environmentally-caused | 1 |
| 159 | ergocalciferol-related | 1 |
| 160 | eti-related | 1 |
| 161 | everolimus-related | 1 |
| 162 | extrapyramidal-related | 1 |
| 163 | fme-associated | 1 |
| 164 | gismondine | 1 |
| 165 | glue-related | 1 |
| 166 | hbo2-related | 1 |
| 167 | health.medical | 1 |
| 168 | hemodynamic-related | 1 |
| 169 | heptadecyl | 1 |
| 170 | htn-associated | 1 |
| 171 | hyperprolactinemia-related | 1 |
| 172 | icd-listed | 1 |
| 173 | infusion-day | 1 |
| 174 | inh-related | 1 |
| 175 | intraanesthetic | 1 |
| 176 | investigator-noted | 1 |
| 177 | ivig-related | 1 |
| 178 | k/mg-solution-associated | 1 |
| 179 | kuse | 1 |
| 180 | laba-related | 1 |
| 181 | life-endangering | 1 |
| 182 | lignocaine-related | 1 |
| 183 | lovastatin-related | 1 |
| 184 | magnesium-related | 1 |
| 185 | manual-selected | 1 |
| 186 | maternal/ | 1 |
| 187 | maternity-related | 1 |
| 188 | mdc-related | 1 |
| 189 | medetomidine-associated | 1 |
| 190 | mediator-less | 1 |
| 191 | medication-attributed | 1 |
| 192 | methyltetrazolethiol | 1 |
| 193 | middle-finger | 1 |
| 194 | migraine- | 1 |
| 195 | mild/moderate/severe | 1 |
| 196 | misoprostol-related | 1 |
| 197 | modality-associated | 1 |
| 198 | month-major | 1 |
| 199 | multivarious | 1 |
| 200 | n-fluoropentyl | 1 |
| 201 | naproxen-associated | 1 |
| 202 | nefazodone-associated | 1 |
| 203 | non-monitorable | 1 |
| 204 | non-rare | 1 |
| 205 | nonlocal-site | 1 |
| 206 | nonsterility | 1 |
| 207 | nonthromboembolic | 1 |
| 208 | ophthalmic-related | 1 |
| 209 | owner-perceived | 1 |
| 210 | panresistant | 1 |
| 211 | para-professional | 1 |
| 212 | parent-nominated | 1 |
| 213 | pbt-related | 1 |
| 214 | pde-related | 1 |
| 215 | pegifn-related | 1 |
| 216 | pellet-derived | 1 |
| 217 | pintrack | 1 |
| 218 | portal-hypertensive | 1 |
| 219 | post-biopsy-positive | 1 |
| 220 | post-expeditional | 1 |
| 221 | post-pbd | 1 |
| 222 | post-rma | 1 |
| 223 | postmanipulative | 1 |
| 224 | ppargamma-mediated | 1 |
| 225 | ppp-related | 1 |
| 226 | pravastatin-related | 1 |
| 227 | pre-biopsy-positive | 1 |
| 228 | propagandistic | 1 |
| 229 | psychiatric-neurological | 1 |
| 230 | ral-related | 1 |
| 231 | reactions.total | 1 |
| 232 | remifentanil-related | 1 |
| 233 | resurfacing-associated | 1 |
| 234 | revascularization/major | 1 |
| 235 | rfb-related | 1 |
| 236 | rhbmp-2-related | 1 |
| 237 | rhtpo-related | 1 |
| 238 | robot-related | 1 |
| 239 | rt-dependent | 1 |
| 240 | safety-associated | 1 |
| 241 | sasp-related | 1 |
| 242 | scienfitic | 1 |
| 243 | self-sustainable | 1 |
| 244 | sex-hormone-related | 1 |
| 245 | sexual-dysfunction | 1 |
| 246 | sight-limiting | 1 |
| 247 | simvastatin-related | 1 |
| 248 | sirolimus-related | 1 |
| 249 | soil-based | 1 |
| 250 | sorafenib-related | 1 |
| 251 | stimulation-associated | 1 |
| 252 | structurally-driven | 1 |
| 253 | suicide-associated | 1 |
| 254 | supplementation-related | 1 |
| 255 | syringe-related | 1 |
| 256 | tcmi-induced | 1 |
| 257 | telaprevir-related | 1 |
| 258 | telephone-transmitted | 1 |
| 259 | ten-latex-expressed | 1 |
| 260 | tens-related | 1 |
| 261 | ticlopidine-related | 1 |
| 262 | top-induced | 1 |
| 263 | tormenting | 1 |
| 264 | trabectedin-related | 1 |
| 265 | trichomoniasis-associated | 1 |
| 266 | ultrafiltration-related | 1 |
| 267 | undersgelser | 1 |
| 268 | undesiderable | 1 |
| 269 | untolerable | 1 |
| 270 | urination-related | 1 |
| 271 | vaccine-attributable | 1 |
| 272 | val-related | 1 |
| 273 | varenicline-related | 1 |
| 274 | vernakalant-related | 1 |
| 275 | vexatious | 1 |
| 276 | vismodegib-related | 1 |
| 277 | years.- | 1 |
| 278 | ⩾g2 | 1 |
| 1 | 'darker | 1 |
| 2 | 1,404,470 | 1 |
| 3 | 11,220 | 1 |
| 4 | 11.local | 1 |
| 5 | 12,907 | 1 |
| 6 | 190-surface | 1 |
| 7 | 2p=0.04 | 1 |
| 8 | 6.06.no | 1 |
| 9 | 9029 | 1 |
| 10 | aas-related | 1 |
| 11 | abcd-related | 1 |
| 12 | acei-related | 1 |
| 13 | acute/long-term | 1 |
| 14 | adequate/three | 3 |
| 15 | adhesive-related | 1 |
| 16 | adnexal/orbital | 2 |
| 17 | advanced-adiabatic | 1 |
| 18 | aed-related | 2 |
| 19 | aes/serious | 2 |
| 20 | agomelatine-related | 1 |
| 21 | alkyldiamine | 1 |
| 22 | altered-chemistry | 1 |
| 23 | ameliorable | 4 |
| 24 | analysis.more | 1 |
| 25 | anesthetic-related | 3 |
| 26 | antiadalimumab | 2 |
| 27 | antibacterial-related | 1 |
| 28 | anticholinergic-emergent | 1 |
| 29 | anticholinergic-related | 1 |
| 30 | antidepressant-associated | 6 |
| 31 | antifungal-related | 1 |
| 32 | atenolol-associated | 1 |
| 33 | atg-related | 1 |
| 34 | atorvastatin-related | 1 |
| 35 | aucbt-related | 1 |
| 36 | benznidazole-related | 1 |
| 37 | best-possible-self | 1 |
| 38 | bgt226-related | 1 |
| 39 | biapenem-related | 1 |
| 40 | biopsy/normal | 1 |
| 41 | bipack | 1 |
| 42 | bleb-related | 7 |
| 43 | bosentan-associated | 1 |
| 44 | bradykinetic | 2 |
| 45 | brain/head | 1 |
| 46 | bupivacaine-related | 1 |
| 47 | cannabinoid-type | 1 |
| 48 | cannabis’s | 1 |
| 49 | cardiophobic | 1 |
| 50 | carlumab-related | 1 |
| 51 | cast-related | 5 |
| 52 | catheterisation-related | 1 |
| 53 | cbt-related | 4 |
| 54 | cdc-defined | 6 |
| 55 | ceramic-related | 1 |
| 56 | chemo-synthetic | 1 |
| 57 | cinitapride-related | 1 |
| 58 | classical-type | 1 |
| 59 | clomipramine-related | 1 |
| 60 | cms-defined | 1 |
| 61 | cmx001-related | 1 |
| 62 | cns-based | 1 |
| 63 | commonly-occurring | 1 |
| 64 | constellation-labeled | 1 |
| 65 | cord-related | 5 |
| 66 | corticosteroid-associated | 3 |
| 67 | corticosteroid-related | 14 |
| 68 | cotc-related | 3 |
| 69 | counter-balancing | 2 |
| 70 | cr-related | 1 |
| 71 | csc-related | 1 |
| 72 | ctx-m-14/15 | 1 |
| 73 | cya-associated | 1 |
| 74 | cyclopropane-containing | 1 |
| 75 | death/severe | 3 |
| 76 | debilitative | 2 |
| 77 | deployment-related | 3 |
| 78 | dermacyn-related | 1 |
| 79 | device-correlated | 1 |
| 80 | device-related | 151 |
| 81 | drink-related | 2 |
| 82 | ebola-specific | 1 |
| 83 | ecp-related | 1 |
| 84 | efficacy.minor | 1 |
| 85 | embolization-related | 1 |
| 86 | emollient-related | 1 |
| 87 | en-related | 2 |
| 88 | endocuff-associated | 1 |
| 89 | entry-related | 1 |
| 90 | environ- | 1 |
| 91 | environmentally-caused | 1 |
| 92 | eps-related | 7 |
| 93 | ergocalciferol-related | 1 |
| 94 | erythropoietin-related | 2 |
| 95 | eti-related | 1 |
| 96 | everolimus-related | 1 |
| 97 | extra-gastrointestinal | 3 |
| 98 | extradigestive | 2 |
| 99 | extrapyramidal-related | 1 |
| 100 | fhab-associated | 3 |
| 101 | fme-associated | 1 |
| 102 | gc-related | 3 |
| 103 | gismondine | 1 |
| 104 | glaucoma-related | 13 |
| 105 | glucocorticoid-related | 5 |
| 106 | glucocorticosteroid-related | 2 |
| 107 | glue-related | 1 |
| 108 | glutamine-related | 2 |
| 109 | grave | 96 |
| 110 | hbo2-related | 1 |
| 111 | health.medical | 1 |
| 112 | hemodynamic-related | 1 |
| 113 | heptadecyl | 1 |
| 114 | high-causality | 2 |
| 115 | htn-associated | 1 |
| 116 | hyperglycemia-related | 6 |
| 117 | hyperprolactinemia-related | 1 |
| 118 | hypothermia-related | 5 |
| 119 | icd-listed | 1 |
| 120 | immobility-related | 5 |
| 121 | incision-related | 4 |
| 122 | influenzal | 2 |
| 123 | infusion-day | 1 |
| 124 | inh-related | 1 |
| 125 | intraanesthetic | 1 |
| 126 | investigator-noted | 1 |
| 127 | ipilimumab-associated | 2 |
| 128 | ivb-related | 2 |
| 129 | ivig-related | 1 |
| 130 | k/mg-solution-associated | 1 |
| 131 | kuse | 1 |
| 132 | laba-related | 1 |
| 133 | lansoprazole-associated | 3 |
| 134 | late-occurring | 13 |
| 135 | lead-related | 18 |
| 136 | life-endangering | 1 |
| 137 | life-threating | 2 |
| 138 | lifethreatening | 2 |
| 139 | lignocaine-related | 1 |
| 140 | lovastatin-related | 1 |
| 141 | lsa-related | 2 |
| 142 | magnesium-related | 1 |
| 143 | manual-selected | 1 |
| 144 | mars-related | 2 |
| 145 | maternal/ | 1 |
| 146 | maternity-related | 1 |
| 147 | mdc-related | 1 |
| 148 | mechanism-related | 5 |
| 149 | medetomidine-associated | 1 |
| 150 | mediator-less | 1 |
| 151 | medically-confirmed | 2 |
| 152 | medication-attributed | 1 |
| 153 | menstrual-associated | 3 |
| 154 | methyltetrazolethiol | 1 |
| 155 | middle-finger | 1 |
| 156 | migraine- | 1 |
| 157 | mild/moderate/severe | 1 |
| 158 | misoprostol-related | 1 |
| 159 | modality-associated | 1 |
| 160 | month-major | 1 |
| 161 | multiform | 8 |
| 162 | multivarious | 1 |
| 163 | n-fluoropentyl | 1 |
| 164 | naproxen-associated | 1 |
| 165 | nefazodone-associated | 1 |
| 166 | non-monitorable | 1 |
| 167 | non-ms-related | 4 |
| 168 | non-ocular | 10 |
| 169 | non-rare | 1 |
| 170 | non-serious | 94 |
| 171 | nonlocal-site | 1 |
| 172 | nonneurological | 2 |
| 173 | nonocular | 44 |
| 174 | nonserious | 60 |
| 175 | nonsterility | 1 |
| 176 | nonthromboembolic | 1 |
| 177 | nonthrombotic | 4 |
| 178 | notch-related | 3 |
| 179 | nsaid-type | 2 |
| 180 | ophthalmic-related | 1 |
| 181 | owner-perceived | 1 |
| 182 | owner-reported | 4 |
| 183 | panresistant | 1 |
| 184 | para-professional | 1 |
| 185 | parent-nominated | 1 |
| 186 | pbt-related | 1 |
| 187 | pde-related | 1 |
| 188 | pegifn-related | 1 |
| 189 | pellet-derived | 1 |
| 190 | pintrack | 1 |
| 191 | platelet-related | 2 |
| 192 | portal-hypertensive | 1 |
| 193 | post-biopsy-positive | 1 |
| 194 | post-expeditional | 1 |
| 195 | post-pbd | 1 |
| 196 | post-rma | 1 |
| 197 | postarthrodesis | 2 |
| 198 | postmanipulative | 1 |
| 199 | ppargamma-mediated | 1 |
| 200 | ppp-related | 1 |
| 201 | pravastatin-related | 1 |
| 202 | pre-biopsy-positive | 1 |
| 203 | probiotic-related | 3 |
| 204 | prolactin-related | 14 |
| 205 | propagandistic | 1 |
| 206 | psychiatric-neurological | 1 |
| 207 | radiotherapy-associated | 2 |
| 208 | ral-related | 1 |
| 209 | reactions.total | 1 |
| 210 | regadenoson-related | 2 |
| 211 | remifentanil-related | 1 |
| 212 | resurfacing-associated | 1 |
| 213 | revascularization/major | 1 |
| 214 | rfb-related | 1 |
| 215 | rhbmp-2-related | 1 |
| 216 | rhtpo-related | 1 |
| 217 | robot-related | 1 |
| 218 | rt-dependent | 1 |
| 219 | safety-associated | 1 |
| 220 | sasp-related | 1 |
| 221 | scienfitic | 1 |
| 222 | secretion-related | 2 |
| 223 | sedation-related | 31 |
| 224 | self-sustainable | 1 |
| 225 | serious | 12,810 |
| 226 | serious/sentinel | 2 |
| 227 | severe/serious | 3 |
| 228 | sex-hormone-related | 1 |
| 229 | sexual-dysfunction | 1 |
| 230 | sight-limiting | 1 |
| 231 | simvastatin-related | 1 |
| 232 | sirolimus-related | 1 |
| 233 | sleeprelated | 2 |
| 234 | soil-based | 1 |
| 235 | sorafenib-related | 1 |
| 236 | stepwise-heated | 2 |
| 237 | steroid-associated | 6 |
| 238 | steroid-related | 26 |
| 239 | stimulation-associated | 1 |
| 240 | structurally-driven | 1 |
| 241 | suicidality-related | 2 |
| 242 | suicide-associated | 1 |
| 243 | supplement-related | 5 |
| 244 | supplementation-related | 1 |
| 245 | syringe-related | 1 |
| 246 | tacrolimus-related | 2 |
| 247 | tcmi-induced | 1 |
| 248 | telaprevir-related | 1 |
| 249 | telephone-transmitted | 1 |
| 250 | ten-latex-expressed | 1 |
| 251 | tens-related | 1 |
| 252 | ticlopidine-related | 1 |
| 253 | top-induced | 1 |
| 254 | tormenting | 1 |
| 255 | trabectedin-related | 1 |
| 256 | transfusion-related | 51 |
| 257 | trichlorobenzenes | 2 |
| 258 | trichomoniasis-associated | 1 |
| 259 | triptan-related | 6 |
| 260 | ultrafiltration-related | 1 |
| 261 | undersgelser | 1 |
| 262 | undesiderable | 1 |
| 263 | untolerable | 1 |
| 264 | urination-related | 1 |
| 265 | vaccine-attributable | 1 |
| 266 | val-related | 1 |
| 267 | varenicline-related | 1 |
| 268 | vernakalant-related | 1 |
| 269 | vestibulo-cerebellar | 2 |
| 270 | vexatious | 1 |
| 271 | vibration-related | 4 |
| 272 | vismodegib-related | 1 |
| 273 | voriconazole-related | 2 |
| 274 | warfarin-associated | 7 |
| 275 | work-associated | 2 |
| 276 | worst-grade | 2 |
| 277 | years.- | 1 |
| 278 | ⩾g2 | 1 |
| 1 | years.- | 1 |
| 2 | migraine- | 1 |
| 3 | environ- | 1 |
| 4 | maternal/ | 1 |
| 5 | 11,220 | 1 |
| 6 | 1,404,470 | 1 |
| 7 | ⩾g2 | 1 |
| 8 | 2p=0.04 | 1 |
| 9 | ctx-m-14/15 | 1 |
| 10 | 12,907 | 1 |
| 11 | 9029 | 1 |
| 12 | post-rma | 1 |
| 13 | antiadalimumab | 2 |
| 14 | cardiophobic | 1 |
| 15 | ebola-specific | 1 |
| 16 | nonthromboembolic | 1 |
| 17 | advanced-adiabatic | 1 |
| 18 | chemo-synthetic | 1 |
| 19 | intraanesthetic | 1 |
| 20 | bradykinetic | 2 |
| 21 | scienfitic | 1 |
| 22 | nonthrombotic | 4 |
| 23 | propagandistic | 1 |
| 24 | brain/head | 1 |
| 25 | post-pbd | 1 |
| 26 | tcmi-induced | 1 |
| 27 | top-induced | 1 |
| 28 | constellation-labeled | 1 |
| 29 | medically-confirmed | 2 |
| 30 | cdc-defined | 6 |
| 31 | cms-defined | 1 |
| 32 | soil-based | 1 |
| 33 | cns-based | 1 |
| 34 | ten-latex-expressed | 1 |
| 35 | environmentally-caused | 1 |
| 36 | stepwise-heated | 2 |
| 37 | cya-associated | 1 |
| 38 | fhab-associated | 3 |
| 39 | ipilimumab-associated | 2 |
| 40 | steroid-associated | 6 |
| 41 | corticosteroid-associated | 3 |
| 42 | suicide-associated | 1 |
| 43 | lansoprazole-associated | 3 |
| 44 | fme-associated | 1 |
| 45 | medetomidine-associated | 1 |
| 46 | nefazodone-associated | 1 |
| 47 | endocuff-associated | 1 |
| 48 | resurfacing-associated | 1 |
| 49 | work-associated | 2 |
| 50 | menstrual-associated | 3 |
| 51 | atenolol-associated | 1 |
| 52 | bosentan-associated | 1 |
| 53 | naproxen-associated | 1 |
| 54 | warfarin-associated | 7 |
| 55 | stimulation-associated | 1 |
| 56 | k/mg-solution-associated | 1 |
| 57 | htn-associated | 1 |
| 58 | trichomoniasis-associated | 1 |
| 59 | antidepressant-associated | 6 |
| 60 | radiotherapy-associated | 2 |
| 61 | safety-associated | 1 |
| 62 | modality-associated | 1 |
| 63 | ppargamma-mediated | 1 |
| 64 | cmx001-related | 1 |
| 65 | rhbmp-2-related | 1 |
| 66 | hbo2-related | 1 |
| 67 | bgt226-related | 1 |
| 68 | laba-related | 1 |
| 69 | hyperglycemia-related | 6 |
| 70 | hyperprolactinemia-related | 1 |
| 71 | hypothermia-related | 5 |
| 72 | glaucoma-related | 13 |
| 73 | lsa-related | 2 |
| 74 | carlumab-related | 1 |
| 75 | bleb-related | 7 |
| 76 | rfb-related | 1 |
| 77 | vismodegib-related | 1 |
| 78 | sorafenib-related | 1 |
| 79 | ivb-related | 2 |
| 80 | mdc-related | 1 |
| 81 | gc-related | 3 |
| 82 | anticholinergic-related | 1 |
| 83 | hemodynamic-related | 1 |
| 84 | ceramic-related | 1 |
| 85 | ophthalmic-related | 1 |
| 86 | anesthetic-related | 3 |
| 87 | probiotic-related | 3 |
| 88 | csc-related | 1 |
| 89 | cotc-related | 3 |
| 90 | lead-related | 18 |
| 91 | abcd-related | 1 |
| 92 | aed-related | 2 |
| 93 | glucocorticoid-related | 5 |
| 94 | steroid-related | 26 |
| 95 | corticosteroid-related | 14 |
| 96 | glucocorticosteroid-related | 2 |
| 97 | cord-related | 5 |
| 98 | device-related | 151 |
| 99 | cinitapride-related | 1 |
| 100 | pde-related | 1 |
| 101 | syringe-related | 1 |
| 102 | benznidazole-related | 1 |
| 103 | voriconazole-related | 2 |
| 104 | bupivacaine-related | 1 |
| 105 | lignocaine-related | 1 |
| 106 | ticlopidine-related | 1 |
| 107 | varenicline-related | 1 |
| 108 | clomipramine-related | 1 |
| 109 | glutamine-related | 2 |
| 110 | agomelatine-related | 1 |
| 111 | sex-hormone-related | 1 |
| 112 | glue-related | 1 |
| 113 | adhesive-related | 1 |
| 114 | ivig-related | 1 |
| 115 | atg-related | 1 |
| 116 | notch-related | 3 |
| 117 | inh-related | 1 |
| 118 | acei-related | 1 |
| 119 | eti-related | 1 |
| 120 | drink-related | 2 |
| 121 | extrapyramidal-related | 1 |
| 122 | antifungal-related | 1 |
| 123 | antibacterial-related | 1 |
| 124 | ral-related | 1 |
| 125 | val-related | 1 |
| 126 | remifentanil-related | 1 |
| 127 | ergocalciferol-related | 1 |
| 128 | misoprostol-related | 1 |
| 129 | biapenem-related | 1 |
| 130 | mechanism-related | 5 |
| 131 | magnesium-related | 1 |
| 132 | triptan-related | 6 |
| 133 | en-related | 2 |
| 134 | pegifn-related | 1 |
| 135 | trabectedin-related | 1 |
| 136 | pravastatin-related | 1 |
| 137 | simvastatin-related | 1 |
| 138 | lovastatin-related | 1 |
| 139 | atorvastatin-related | 1 |
| 140 | prolactin-related | 14 |
| 141 | erythropoietin-related | 2 |
| 142 | incision-related | 4 |
| 143 | transfusion-related | 51 |
| 144 | sedation-related | 31 |
| 145 | urination-related | 1 |
| 146 | vibration-related | 4 |
| 147 | ultrafiltration-related | 1 |
| 148 | catheterisation-related | 1 |
| 149 | supplementation-related | 1 |
| 150 | embolization-related | 1 |
| 151 | secretion-related | 2 |
| 152 | regadenoson-related | 2 |
| 153 | dermacyn-related | 1 |
| 154 | rhtpo-related | 1 |
| 155 | ecp-related | 1 |
| 156 | ppp-related | 1 |
| 157 | sasp-related | 1 |
| 158 | cr-related | 1 |
| 159 | telaprevir-related | 1 |
| 160 | aas-related | 1 |
| 161 | non-ms-related | 4 |
| 162 | tens-related | 1 |
| 163 | eps-related | 7 |
| 164 | mars-related | 2 |
| 165 | tacrolimus-related | 2 |
| 166 | everolimus-related | 1 |
| 167 | sirolimus-related | 1 |
| 168 | cbt-related | 4 |
| 169 | aucbt-related | 1 |
| 170 | pbt-related | 1 |
| 171 | platelet-related | 2 |
| 172 | vernakalant-related | 1 |
| 173 | emollient-related | 1 |
| 174 | supplement-related | 5 |
| 175 | deployment-related | 3 |
| 176 | robot-related | 1 |
| 177 | cast-related | 5 |
| 178 | entry-related | 1 |
| 179 | suicidality-related | 2 |
| 180 | immobility-related | 5 |
| 181 | maternity-related | 1 |
| 182 | sleeprelated | 2 |
| 183 | device-correlated | 1 |
| 184 | parent-nominated | 1 |
| 185 | manual-selected | 1 |
| 186 | investigator-noted | 1 |
| 187 | owner-reported | 4 |
| 188 | icd-listed | 1 |
| 189 | telephone-transmitted | 1 |
| 190 | medication-attributed | 1 |
| 191 | owner-perceived | 1 |
| 192 | pellet-derived | 1 |
| 193 | 190-surface | 1 |
| 194 | worst-grade | 2 |
| 195 | adequate/three | 3 |
| 196 | self-sustainable | 1 |
| 197 | undesiderable | 1 |
| 198 | untolerable | 1 |
| 199 | ameliorable | 4 |
| 200 | non-monitorable | 1 |
| 201 | vaccine-attributable | 1 |
| 202 | gismondine | 1 |
| 203 | alkyldiamine | 1 |
| 204 | nsaid-type | 2 |
| 205 | cannabinoid-type | 1 |
| 206 | classical-type | 1 |
| 207 | non-rare | 1 |
| 208 | mild/moderate/severe | 1 |
| 209 | death/severe | 3 |
| 210 | analysis.more | 1 |
| 211 | kuse | 1 |
| 212 | nonlocal-site | 1 |
| 213 | grave | 96 |
| 214 | portal-hypertensive | 1 |
| 215 | postmanipulative | 1 |
| 216 | debilitative | 2 |
| 217 | pre-biopsy-positive | 1 |
| 218 | post-biopsy-positive | 1 |
| 219 | extradigestive | 2 |
| 220 | best-possible-self | 1 |
| 221 | counter-balancing | 2 |
| 222 | lifethreatening | 2 |
| 223 | cyclopropane-containing | 1 |
| 224 | life-endangering | 1 |
| 225 | late-occurring | 13 |
| 226 | commonly-occurring | 1 |
| 227 | life-threating | 2 |
| 228 | sight-limiting | 1 |
| 229 | tormenting | 1 |
| 230 | bipack | 1 |
| 231 | pintrack | 1 |
| 232 | health.medical | 1 |
| 233 | psychiatric-neurological | 1 |
| 234 | nonneurological | 2 |
| 235 | 11.local | 1 |
| 236 | biopsy/normal | 1 |
| 237 | extra-gastrointestinal | 3 |
| 238 | para-professional | 1 |
| 239 | post-expeditional | 1 |
| 240 | adnexal/orbital | 2 |
| 241 | reactions.total | 1 |
| 242 | influenzal | 2 |
| 243 | serious/sentinel | 2 |
| 244 | methyltetrazolethiol | 1 |
| 245 | heptadecyl | 1 |
| 246 | n-fluoropentyl | 1 |
| 247 | acute/long-term | 1 |
| 248 | multiform | 8 |
| 249 | structurally-driven | 1 |
| 250 | sexual-dysfunction | 1 |
| 251 | 6.06.no | 1 |
| 252 | vestibulo-cerebellar | 2 |
| 253 | non-ocular | 10 |
| 254 | nonocular | 44 |
| 255 | middle-finger | 1 |
| 256 | 'darker | 1 |
| 257 | undersgelser | 1 |
| 258 | month-major | 1 |
| 259 | revascularization/major | 1 |
| 260 | efficacy.minor | 1 |
| 261 | trichlorobenzenes | 2 |
| 262 | postarthrodesis | 2 |
| 263 | mediator-less | 1 |
| 264 | multivarious | 1 |
| 265 | serious | 12,810 |
| 266 | non-serious | 94 |
| 267 | severe/serious | 3 |
| 268 | aes/serious | 2 |
| 269 | nonserious | 60 |
| 270 | vexatious | 1 |
| 271 | cannabis’s | 1 |
| 272 | panresistant | 1 |
| 273 | rt-dependent | 1 |
| 274 | anticholinergic-emergent | 1 |
| 275 | infusion-day | 1 |
| 276 | altered-chemistry | 1 |
| 277 | high-causality | 2 |
| 278 | nonsterility | 1 |